Identification and partial characterization of differentially expressed mRNAs in normal human endometria and endometrial carcinomas by differential display RT-PCR

Molecular Human Reproduction

Volumn 6, Issue 8, 2000, Pages 712-718

  Foca, C ^a,b   Rice, G E ^a,b   Quinn, M A ^a   Moses, E K ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Differential expression; Endometrial carcinoma; Endometrium; Sequence analysis

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; DNA SEQUENCE; ENDOMETRIUM CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0033872743     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/6.8.712     Document Type: Article

References (19)

1. Post surgical surveillance of patients with FIGO/Stage I/II endometrial carcinoma
2. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
3. Cisplatin, doxorubicin and cyclophosphamide (PAC) followed by radiation therapy in high risk endometrial carcinoma
4. P53 expression as a prognostic indicator of 5 year survival in endometrial cancer
5. HER-2/neu expression: A major prognostic factor in endometrial cancer
6. Surgery followed by radiotherapy in endometrial cancer: Analysis of survival and patterns of failure
7. P53 overexpression in early stage endometrial cancer
8. A multi-center phase II study with triptorelin (sustained release LHRH agonist) in advanced or recurrent endometrial carcinoma: A French Anti-cancer Federation study
9. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
10. Distribution and cloning of eukaryotic messenger RNAs by means of differential display-refinements and optimisation
11. Laparascopic lymphadenectomy and vaginal or laparascopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer. Morbidity and Survival
12. Case-control study of endogenous steroid hormones and endometrial cancer
13. Expression of ras p21 in normal and neoplastic human endometrium
14. Significance of epidermal growth factor receptor expression in primary human endometrial cancer
15. Identification of a novel growth factor responsive gene in vascular smooth muscle cells
16. SM-20 is a novel 40 kD protein whose expression in the arterial wall is restricted to smooth muscle
17. Risk of endometrial cancer following estrogen replacement with or without progestins
18. Comparison of intracellular tumour marker concentrations in different gynaecological tissues and their malignant tumours
19. Value of glutathione-S-transferase PI and the oncogene products c-jun, c-fos, c-h-ras and c-myc as a prognostic indicator in endometrial carcinomas